On Friday, CFRA made a significant adjustment to its rating on Globe Life Inc. (NYSE: NYSE:), shifting from Hold to Sell and reducing the price target to $55.00 from $63.00. The new target price is based on a multiple of 4.8 times CFRA’s 2024 operating earnings per share (EPS) estimate of $11.50. This valuation is below the average for Globe Life’s peers, which typically trade at 8.5 times earnings, but aligns with other life insurers facing distress.
The downgrade follows a tumultuous trading session on Thursday, where Globe Life shares plummeted by over 50%. This dramatic decline was triggered by the publication of a short seller report, which alleged widespread insurance fraud within the company. The report claimed that these fraudulent activities were not only evident but had been reported numerous times, yet ignored by the management.
In response to the allegations, Globe Life issued a statement vehemently denying the claims made by the short seller, describing the report as “wildly misleading.” Despite the company’s rebuttal, CFRA’s analysis highlights an ongoing investigation by the Department of Justice into Globe Life’s practices.
CFRA’s analyst expressed concerns regarding the management at Globe Life, particularly criticizing their handling of investor communications related to the existing allegations and investigation. This has led to the recommendation for investors to avoid Globe Life’s shares for the time being.
InvestingPro Insights
In light of the recent CFRA downgrade for Globe Life Inc. (NYSE: GL), investors may benefit from additional context provided by InvestingPro data and tips. Globe Life’s market capitalization currently stands at $4.99 billion, with a notably low P/E ratio of 5.2, indicating that the stock may be trading at a discount relative to its near-term earnings growth. This aligns with the InvestingPro Tip that suggests the stock is trading at a low P/E ratio relative to near-term earnings growth, which could interest value investors.
Despite the short seller’s allegations and the resulting stock price volatility, Globe Life has a history of returning value to shareholders, as evidenced by its dividend track record. The company has not only raised its dividend for 8 consecutive years but has maintained dividend payments for an impressive 54 consecutive years. This is a testament to the company’s long-term commitment to shareholder returns, a factor that might reassure investors looking for stable dividend-paying stocks.
Moreover, the stock’s recent performance shows a significant decrease over the last month, with a 1-month price total return of -13.08%. This could reflect the market’s reaction to the allegations and CFRA’s downgrade. For investors considering Globe Life’s stock, it may be prudent to monitor the situation closely, especially with the next earnings date scheduled for April 17, 2024. For a deeper analysis and more InvestingPro Tips, interested readers can explore the full list of insights at https://www.investing.com/pro/GL, which includes additional tips not covered here. To access these insights, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
